LONDON: Roquefort Therapeutics plc (LSE:ROQ), a Main Market-listed biotech firm, said Monday it has entered into a binding term sheet to acquire Coiled Therapeutics, Inc., a clinical-stage oncology company spun out from A2A Pharmaceuticals, in a reverse takeover valued at…
eToro shares rose sharply in its Nasdaq debut on Wednesday, opening at $69.69—a 34% premium to its $52 IPO price—boosting its market capitalization to $5.6 billion. Shares remained up over 30% in early trading. The Israel-based brokerage sold nearly 6…
LONDON, UK: Arix Bioscience plc, a global venture capital company focused on investing in and building breakthrough biotech companies, notes that its portfolio company, Pyxis Oncology Inc., has announced the pricing of its initial public offering of 10.5 million shares…
DUBLIN: Malin Corporation notes that its investee company, Immunocore, has announced the pricing of its initial public offering (IPO) of 9.9 million American Depositary Shares (ADSs) representing 9.9 million ordinary shares at an initial public offering price of $26 per…
PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix is a clinical-stage biotechnology company focused on developing first-in-class product candidates that use proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy and increasing the…